Stock listing

LS Exchange:A2PV0Q Telo Genomics Corp. Aktie

German listing (LS Exchange) of Telo Genomics Corp. · home listing TSXV:TELO

Follow Telo Genomics Corp. into a list and get an email when it puts out news.

Home listing price · TSXV:TELO

$0.04 CAD -0.00 (-11.1%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSXV:TELO

Past year -33.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.04 – $0.04 CADNov 20, 2026
Volume
115,500 sharesNov 20, 2026
Market cap
$4.02M CADAt the close on Nov 20, 2026 · price × 100.4M shares outstanding
52-week range
$0.025 – $0.105 CADLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$2,732 CADMedian day 5,000 shares · 27 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Telo Genomics Corp. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
TSXV:TELO · Home$0.04 CAD-0.005 (-11.1%)115,500$0.04$0.04$0.04$0.045Close on Nov 20, 2026
OTC:TDSGF$0.025 USD-0.005 (-15.7%)200$0.025$0.025$0.025$0.030Close on Nov 17, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TSXV:TELO · CAD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.04-0.005-11.1%$0.04$0.04$0.04115,500
$0.045-0.005-10.0%$0.05$0.055$0.045112,330
$0.05+0.005+11.1%$0.05$0.05$0.0519,000
$0.0450.000.0%$0.05$0.05$0.04541,000
$0.0450.000.0%$0.045$0.045$0.0450
$0.0450.000.0%$0.045$0.045$0.0450
$0.0450.000.0%$0.045$0.045$0.0450
$0.0450.000.0%$0.045$0.045$0.0450
$0.0450.000.0%$0.045$0.045$0.0450
$0.0450.000.0%$0.045$0.045$0.0450
$0.0450.000.0%$0.045$0.045$0.0450
$0.045-0.005-10.0%$0.05$0.05$0.0456,673
$0.050.000.0%$0.05$0.05$0.050
$0.050.000.0%$0.05$0.05$0.050
$0.050.000.0%$0.05$0.05$0.057,722
$0.050.000.0%$0.05$0.05$0.0510,000
$0.050.000.0%$0.05$0.05$0.050
$0.050.000.0%$0.05$0.05$0.050
$0.050.000.0%$0.05$0.05$0.055,000
$0.05-0.005-9.1%$0.05$0.05$0.056,000
$0.0550.000.0%$0.055$0.055$0.0550
$0.055-0.015-21.4%$0.06$0.06$0.0558,000
$0.07+0.01+16.7%$0.07$0.07$0.071,000
$0.060.000.0%$0.06$0.06$0.060
$0.06-0.01-14.3%$0.07$0.07$0.06101,022
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.07$0.07$0.070
$0.070.000.0%$0.075$0.08$0.07258,354
$0.07+0.02+40.0%$0.06$0.075$0.055185,463
$0.05-0.005-9.1%$0.055$0.055$0.0536,000
$0.055+0.005+10.0%$0.065$0.105$0.045153,000
$0.05-0.005-9.1%$0.055$0.06$0.0554,100
$0.055-0.005-8.3%$0.055$0.055$0.05512,158
$0.06+0.01+20.0%$0.05$0.065$0.05300,352
$0.050.000.0%$0.05$0.05$0.055,000
$0.05+0.015+42.9%$0.035$0.05$0.035218,000
$0.0350.000.0%$0.035$0.035$0.025425,500
$0.0350.000.0%$0.035$0.035$0.03550,000
$0.0350.000.0%$0.035$0.035$0.0350
$0.0350.000.0%$0.04$0.04$0.03511,000
$0.035-0.005-12.5%$0.04$0.04$0.03551,400
$0.040.000.0%$0.04$0.04$0.043,550
$0.040.000.0%$0.04$0.05$0.035184,000
$0.040.000.0%$0.04$0.04$0.040
$0.040.000.0%$0.04$0.04$0.040
$0.04-0.005-11.1%$0.04$0.04$0.04145,000
$0.0450.000.0%$0.045$0.05$0.045463,026
$0.0450.000.0%$0.045$0.045$0.0450
$0.0450.000.0%$0.045$0.045$0.0450
$0.0450.000.0%$0.045$0.045$0.0450
$0.045+0.005+12.5%$0.045$0.045$0.04540,000
$0.040.000.0%$0.04$0.04$0.040
$0.04+0.005+14.3%$0.04$0.04$0.04102,000
$0.035-0.005-12.5%$0.035$0.035$0.03539,000
$0.04-0.005-11.1%$0.045$0.045$0.04133,000
$0.0450.000.0%$0.045$0.045$0.0450
$0.0450.000.0%$0.045$0.045$0.0450
$0.0450.000.0%$0.045$0.045$0.0453,015
$0.045-0.005-10.0%$0.045$0.045$0.04108,000
$0.050.000.0%$0.05$0.05$0.050
$0.050.000.0%$0.05$0.05$0.052,000
$0.050.000.0%$0.05$0.05$0.050
$0.050.000.0%$0.05$0.05$0.050
$0.05+0.005+11.1%$0.04$0.05$0.04193,000

Splits

2 splits since 2016 · TSXV:TELO · every price before a split is adjusted for it

DayRatioWhat
1-for-5Consolidation
1-for-2Consolidation
Ticker
LS Exchange:A2PV0Q
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
LS Exchange
Currency
EUR

What changed lately

Latest news

Telo Genomics Grants Stock Options

Aug 4, 2026

Closed $0.045 (0.0%) on Aug 4, 2026

All Telo Genomics Corp. news

Financings

  • Secured convertible debentures

    Nov 20, 2026 · US$698,470

    Announced: up to C$1M · C$0.05 · Warrants at C$0.08 for 12 months

    Use of proceeds: Lab trials and general working capital

    Announced Nov 20, 2026

  • Non-transferable secured convertible debentures

    Feb 27, 2026 · US$614,125

    Tranche closed: C$840,000 raised · C$0.05 · Warrants at C$0.08 for 12 months · free to trade Jun 18, 2026

    Use of proceeds: Working capital and general corporate purposes

    Announced Jan 19, 2026 · Tranche closed Feb 18, 2026 · Made bigger Feb 27, 2026

  • Private placement of units

    Dec 23, 2024 · US$1.77M

    Closed: C$2.55M raised · C$0.1 a unit · Warrants at C$0.15 for 36 months · free to trade Apr 24, 2025

    Insiders: A director of the Company acquired 150,000 Units

    Use of proceeds: Partnering multiple myeloma prognostics, SMART program for TeloViewSMM, MRD validation, prostate cancer test development, working capital

    Announced Dec 12, 2024 · Closed Dec 23, 2024

Read by 6ix AI from the company's releases

Decks

Telo Genomics Corp. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
21 in the last 12 months · 95 in all · newest Nov 20, 2026 · oldest 2016
Decks
1 deck · latest December 2025

Where Telo Genomics Corp. is listed

ListingExchangeCountryCurrency
TSXV:TELO · Home listingTSXVCanadaCAD
OTC:TDSGFOTCUnited StatesUSD
LS Exchange:A2PV0Q · This pageLS ExchangeGermanyEUR
Lang & Schwarz:A2PV0QLang & SchwarzGermanyEUR
Munich:3D0AMunichGermanyEUR
Cboe Canada:TELOCboe CanadaCanadaCAD
gettex:3D0AgettexGermanyEUR
Frankfurt:3D0AFrankfurtGermanyEUR
Stuttgart:3D0AStuttgartGermanyEUR
Tradegate:3D0ATradegateGermanyEUR

Log in to ask 6ix AI your own questions about Telo Genomics Corp.